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Abstract CCN5 is a secreted heparin- and estrogen-
regulated matricellular protein that inhibits vertebrate
smooth muscle cell proliferation and motility. CCN5 is
expressed throughout murine embryonic development in
most organs and tissues. However, after embryonic devel-
opment is complete, we hypothesized that CCN5 distribu-
tion would be largely restricted to small set of tissues,
including smooth muscle cells of the arteries, uterus,
airway, and digestive tract. Because CCN5 inhibits prolif-
eration of smooth muscle cells in vitro, it might function to
prevent excessive growth in vivo. In contrast, another
member of the CCN family, CCN2, promotes smooth
muscle cell proliferation in vitro, and thus it was expected
that its expression levels would be low in uninjured normal
adult tissues. Frozen sections from adult tissues and organs
were analyzed immunohistochemically using anti-CCN5
and anti-CCN2 antibodies. Both proteins were detected in
arteries, the uterus, bronchioles, and the digestive tract as
expected, and also in many other tissues including the
pancreas, spleen, liver, skeletal muscle, ovary, testis,
thymus, brain, olfactory epithelium, and kidney. CCN5
and CCN2 protein was found in smooth muscle, endothelial
cells, epithelial cells, skeletal muscle, cells of the nervous
system, and numerous other cell types. In many cells, both
CCN5 and CCN2 was present in the nucleus. Rather than
having opposite patterns of localization, CCN5 and CCN2
often had similar sites of expression. The wide distribution
of both CCN5 and CCN2 suggests that both proteins have
additional biological functions beyond those previously
identified in specific cellular and pathological models.
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Introduction
The CCN family consists of six highly conserved, cysteine-
rich cell surface and extracellular matrix (ECM)-associated
proteins (Brigstock 2003; Perbal 2004). CCN proteins
regulate cell proliferation and motility, as well as numerous
other biological processes. They have been demonstrated to
have key roles in a variety of pathophysiologic models
(Brigstock et al. 2005). With the exception of CCN5, all
CCN proteins have a distinctive sequence consisting of four
polypeptide modules: (1) Insulin-Like Growth Factor-
Binding Protein (IGF-BP), (2) von Willebrand Factor-C
(VWC), (3) thrombospondin-1 (TSP1), and (4) a carboxy-
terminal (CT) domain. CCN proteins are typically present
on the surface of the cells that secreted them and they have
been called matricellular proteins because of their strong
association with the ECM. Some might serve as ECM-
bound ligands for integrin-mediated signaling between the
cells and the matrix (Brigstock et al. 2005).
The CCN5 gene, known previously as Cop-1 (Delmolino
et al. 1997, 2001), rCop-1 (Zhang et al. 1998), Wisp-2
(Pennica et al. 1998), and CTGF-L (Kumar et al. 1999),
encodes the only CCN protein that lacks the CT domain
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(Gray and Castellot 2004). Because of this structural
difference, it was expected that many functions of CCN5
would be significantly different from those mediated by the
four-domain CCN proteins such as CCN2. In some model
systems, CCN5 seems to have opposite or complementary
functions to those of the other CCN proteins, leading to the
notion that CCN5 is an antagonist (either pharmacological-
ly or biologically) of the four-domain CCN proteins (Gray
and Castellot 2004).
Previous studies of animal tissues have revealed that
CCN5 is normally expressed in the rat uterus in smooth
muscle, glandular epithelium, and the endometrium (Mason
et al. 2004), rat arterial smooth muscle and endothelium
(Lake et al. 2003), and human fetal bone (Kumar et al.
1999). Studies of CCN5 mRNA expression by Northern
blot, in situ hybridization (ISH), and quantitative polymer-
ase chain reaction (Q-PCR) indicate that additional sites of
CCN5 mRNA expression might include adult brain, heart,
lung, colon, prostate gland, testis, ovary, skeletal muscle,
and most cell types in bone (Delmolino et al. 2001; Kumar
et al. 1999; Pennica et al. 1998).
The CCN2 gene encodes a four-domain protein also
known as connective tissue growth factor (CTGF) (Moussad
and Brigstock 2000). CCN2 is mitogenic for fibroblasts,
smooth muscle cells, vascular endothelial cells (Bradham
et al. 1991), hepatic stellate cells (Gao et al. 2004),
chondrocytes, and osteoblasts (Takigawa et al. 2003). In
addition to proliferation, CCN2 also promotes cellular
adhesion, migration (Babic et al. 1999), chemotaxis, and
production of ECM molecules (Tong and Brigstock 2006).
CCN2 has a role in tissue growth and regeneration, and has
been studied extensively in skeletal and vascular systems.
Over-expression of CCN2 has been implicated in patho-
logical disorders, including angiogenesis in tumors (Rachfal
et al. 2004; Ivkovic et al. 2003), atherosclerosis (Cicha
et al. 2005), and fibrotic diseases (Leask 2004). CCN2 is
normally expressed in vascular endothelial cells, osteo-
blasts, hypertrophic chondrocytes, brain, kidney, and
numerous tissues in the embryo (Takigawa et al. 2003;
Ivkovic et al. 2003; Friedrichsen et al. 2005).
To further describe the biological functions of the CCN5
protein, it is necessary to determine its normal protein
distribution in vivo. The earlier studies of CCN5 expres-
sion patterns were based largely on Northern blot analyses
of RNA samples prepared from isolated vertebrate tissues.
Because CCN proteins are secreted, the pattern of mRNA
expression might not match that of protein distribution. It
is also possible that the degradation rate of the CCN5
protein is very slow, and CCN5 might persist in tissues
long after the mRNA is destroyed. Thus, in order to fully
describe CCN5 expression patterns, we examined CCN5
protein distribution in diverse rodent tissues using immu-
nohistochemistry. We expected that (1): CCN5 protein
would be found mostly in smooth muscle, glandular
epithelium, and endothelial cells, and only slightly in other
tissues. (2): CCN2 protein expression would be highest in
endothelial cells, bone, cartilage, and connective tissue,
and much lower in other tissues. (3): Because the
biological effects of CCN5 expression have been observed
to be opposite to that of CCN2, the two proteins would
have opposite and non-overlapping patterns of expression.
In contrast to our expectations, the immunohistochemistry
results demonstrated that: (1) both CCN2 and CCN5
proteins are widely distributed in all tissues tested in both
rat and mouse, (2) CCN2 and CCN5 have overlapping and
very similar patterns of distribution, and (3) many cell




Animal use protocols were reviewed and approved by the
Institutional Animal Care and Use Committee at Tufts
University. Albino Sprague–Dawley rats (200–225 g) and
C57BL6/J mice were obtained from Charles River
Laboratories (Wilmington, MA). Animals were maintained
on a 14 h light and 10 h dark cycle with lights on at
0400 h and off at 1800 h. Food and water were available
ad libitum. Prior to collection of tissues, animals were
euthanized by carbon dioxide overdose followed by
thoracotomy. Some mice were euthanized by thoracotomy
after deep anesthesia with sodium pentobarbital as
described below.
Tissue samples
Tissue samples and organs were dissected out and rinsed
in PBS, and then fixed for 2–4 h in 4% paraformaldehyde
in 0.05 M sodium phosphate buffer, pH 7.2. To obtain
better fixation for some tissues (heart, kidney, lung, liver),
some mice were deeply anesthetized with sodium pento-
barbital and then perfused intracardially with PBS fol-
lowed by 4% paraformaldehyde. Tissues and organs were
then dissected out and post-fixed for 1 h in 4% parafor-
maldehyde. After fixation, tissues were rinsed in PBS,
cryoprotected in 30% sucrose/PBS, and then frozen in
OCT embedding medium (Tissue-Tek) on dry ice. Frozen
tissue samples were sectioned (7 μM) using a Leica
CM3050S cryostat and collected onto Fisher brand Plus
slides and stored at −20°C. We analyzed frozen sections
instead of sections embedded in paraffin to avoid any
potential blocking of CCN protein antigens that could
occur during dehydration and heating.
146 M. Gray, et al.
Immunohistochemistry
Immunohistochemical analysis was performed using the
Vectastain Elite ABC kit (PK 6101; Vector Laboratories;
Burlingame, CA). Slides were incubated with anti-CCN5
(1:500 in PBS; affinity purified polyclonal antibody to a rat
peptide consisting of amino acids 103–117 of the CCN5
VWC domain) and anti-CCN2 (1:500 in PBS, affinity-
purified polyclonal antibody to a mouse peptide that includes
amino acids 223–348 of the CCN2 protein; ab6992; Abcam,
Inc.; Cambridge, MA) overnight at 4°C. The anti-CCN5
antibody has been well-characterized in previous experiments
(Lake et al. 2003; Mason et al. 2004). Its specificity has been
verified by Western blot analysis, in which a prominent
28 kDa band is revealed in growth-arrested rat smooth
muscle cells and in rat smooth muscle cells transfected with
recombinant adenovirus that express the full-length rat
CCN5 cDNA sequence (Lake et al. 2003). A second anti-
CCN5 antibody against a rat peptide from the IGF-BP
domain produced the same Western blot results as the anti-
CCN5 antibody used in the present experiments (data not
shown). The specificity of the CCN2 antibody used in the
present experiments has been verified by Western blot
analysis, in which a prominent 38 kDa band is detected in
human fibroblasts and neurons (Ueberham et al. 2003).
After incubation with the secondary antibody (biotiny-
lated goat anti-rabbit IgG) and the ABC reagent (30 min each
at room temperature), and a 5-min staining with the DAB
peroxidase substrate reagent (SK 4100; Vector Laboratories;
Burlingame, CA), the slides were counterstained with Harris
modified hematoxylin with acetic acid (Fisher) for 1 min. All
slides were dehydrated and embedded in permanent mount-
ing medium (#13510; DPX Mountant; Electron Microscopy
Sciences; Hatfield, PA) and photographed using a micro-
scope (Zeiss Axioscope) and a digital camera system (SPOT;
Diagnostic Instruments). The magnification used for all
examples was 200×, except Figs. 10 and 13 (630×).
Results
Immunohistochemistry analysis revealed CCN5 and CCN2
staining in numerous cell types of most tissues and organs
analyzed, in both mouse and rat. The staining patterns of
mouse tissue samples stained with anti-CCN5 were very
similar to those obtained with anti-CCN2 (Figs. 1, 2, 4, 5, 6,
7, 10, 11, 13; Table 1). Rat tissues had very similar patterns
of CCN5 and CCN2 staining (Figs. 3, 8, 9, 12, 13; Table 2).
Cardiovascular and pulmonary systems
We have previously demonstrated high levels of CCN5 in
cardiovascular cells. High levels of CCN5 protein were
Fig. 1 Immunohistochemical analysis of the mouse heart using anti-
CCN2 and anti-CCN5. Left ventricular myocardium samples from a
mouse were fixed by intracardial perfusion immediately post-mortem.
The 7 μm frozen tissue sections are transversely oriented before
incubation with anti-CCN2 and anti-CCN5. Some myocardial cells
demonstrate nuclear localization of both CCN2 and CCN5
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Fig. 2 Immunohistochemical analysis of the mouse lung using anti-
CCN2 and anti-CCN5. Lung samples were obtained from a mouse
that was fixed by intracardial perfusion immediately post-mortem. In
each panel is a transversely-oriented 7 μm lung tissue section that
reveals a large bronchiole (BR) with a prominent lumenal columnar
epithelium (EP) surrounded by a thin layer of circumferential smooth
muscle (SM), large thin-walled pulmonary veins (PV), some small
pulmonary arteries (PA), and numerous alveolar air sacs. All types of
cells in the mouse lung demonstrate some nuclear localization of both
CCN2 and CCN5
Fig. 3 Immunohistochemical analysis of the rat lung using anti-
CCN2 and anti-CCN5. Each panel includes a transversely-oriented
7 μm lung tissue section that reveals a portion of the alveolar network.
As in the mouse lung (Fig. 2), some cells in the rat lung demonstrate
nuclear localization of both CCN2 and CCN5
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Fig. 4 Immunohistochemical analysis of the mouse stomach wall
using anti-CCN2 and anti-CCN5. The 7 μm transversely-oriented
tissue sections reveal (from left to right) the muscularis externa (ME)
and muscularis mucosae (MM) smooth muscle layers, secretory
Brunner’s glands (BG), crypts of Lieberkuhn or gastric pits (GP),
gastric villi (GV), and surface mucous cells. Cells at the base of the
gastric pits demonstrate nuclear localization of both CCN2 and CCN5
Fig. 5 Immunohistochemical analysis of the mouse duodenum using
anti-CCN2 and anti-CCN5. The tissue sections (7 μm oblique) include
(from left to right) submucosal Brunner’s glands (BG), muscularis
mucosae (MM; a smooth muscle layer), and the mucosa with
numerous villi and pits. Some cells in the villi demonstrate nuclear
localization of CCN2 and CCN5
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Fig. 6 Immunohistochemical analysis of the mouse liver using anti-
CCN2 and anti-CCN5. Liver samples were obtained from a mouse
that was fixed by intracardial perfusion immediately post-mortem. The
tissue sections (7 μm transverse) display cords of hepatocytes
surrounded by sinusoids, large central veins (CV), and smaller portal
vein branches
Fig. 7 Immunohistochemical analysis of the mouse kidney using anti-
CCN2 and anti-CCN5. Kidney samples were obtained from a mouse
that was fixed by intracardial perfusion immediately post-mortem. The
tissue sections (7 μm parasagittal) are from the renal cortex and
include renal corpuscles with Bowman’s capsules and glomeruli (G)
interspersed within a dense network of convoluted tubules. Many of
the cells in the mouse kidney demonstrate nuclear localization of
CCN2 and CCN5
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detected in rat arterial smooth muscle and lumenal epithelium
and in cultured aortic smooth muscle cells (Lake et al. 2003).
Immunohistochemical analysis of mouse heart tissue
revealed similar patterns of both CCN2 and CCN5 protein
distribution (Fig. 1). Both proteins were found throughout
the cytoplasm of the ventricular myocardium. Both CCN2
and CCN5 were found in the atria and in the valves (data
not shown). To our surprise, most nuclei in the myocardium
displayed nuclear localization of both CCN2 and CCN5
(Fig. 13). Rat heart sections revealed the same pattern of
CCN2 and CCN5 as that of the mouse (data not shown). In
pectoralis major muscle and several other skeletal muscles,
we detected a similar pattern of widespread CCN2 and
CCN5 protein distribution (data not shown).
Both CCN2 and CCN5 displayed similar ubiquitous dis-
tribution patterns in both mouse lung (Fig. 2) and rat lung
(Fig. 3). Both proteins were observed in the cytoplasm of
alveolar and bronchiolar epithelial cells, endothelial cells,
and smooth muscle cells, and also in many nuclei of all
lung cell types (Fig. 13). We have also detected high levels
of CCN2 and CCN5 on the surface and in the nuclei of
cultured smooth muscle cells from mouse, rat, and human
bronchial trachealis muscle (data not shown).
Gastrointestinal system
Several tissues from the mouse and rat gastrointestinal system
were analyzed for the presence of CCN2 and CCN5,
including the stomach, duodenum, and liver (Figs. 4, 6). All
cells in mouse stomach wall (fundus portion) displayed both
CCN2 and CCN5 in the cytoplasm (Fig. 4). Both proteins
were observed in many nuclei in gastric pit cells in the deep
zone of the mucosa (Figs. 4, 13).
Cells of the mouse duodenum revealed both CCN2 and
CCN5 in patterns similar to that observed in the stomach
(Fig. 5). CCN2 and CCN5 protein were found in the
cytoplasm of cells of the Brunner’s glands, muscularis
mucosae, the crypts, and the villi, and in many nuclei of
cells in Brunner’s glands and villi.
Both mouse liver (Fig. 6) and rat liver (data not shown)
displayed ubiquitous distribution of both CCN2 and CCN5
in the cytoplasm of all cell types, including hepatocytes and
endothelial cells.
Urogenital system
The tissues of the urogenital system in both mouse and rat
revealed similar patterns of ubiquitous CCN2 and CCN5
distribution (Figs. 7, 8, 9). In the kidneys of both mice and
rats, both proteins were present in the cytoplasm and many
nuclei of all cell types present, including distal and
proximal tubular cells, glomerular endothelial cells, and
mesangial cells (Figs. 7, 8).
Fig. 8 Immunohistochemical analysis of the rat kidney using anti-
CCN2 and anti-CCN5. The tissue sections (7 μm parasagittal) are
from the renal cortex and include renal corpuscles with Bowman’s
capsules and glomeruli (G) interspersed within a dense network of
convoluted tubules. Many of the cells in the rat kidney, particularly
those from the convoluted tubules, demonstrate nuclear localization of
CCN2 and CCN5
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The rat ovary (Fig. 9) and mouse ovary (data not shown)
revealed both CCN2 and CCN5 in all cell types, including
stromal cells, thecal cells, granulosa cells, and oocytes.
Most nuclei in the ovary demonstrated both CCN2 and
CCN5 (Figs. 9, 13).
Endocrine system
Both CCN2 and CCN5 were present in other endocrine
glands and in immune tissues. In the mouse pancreas,
CCN2 and CCN5 were expressed throughout the cytoplasm
of exocrine cells (data not shown). No nuclear staining for
CCN2 or CCN5 was observed in the pancreas.
The mouse thymus revealed CCN2 and CCN5 protein
throughout both the medulla and cortex (Fig. 10). Both
proteins were present in the cytoplasm and most nuclei of
lymphocytes., and most lymphocyte nuclei had high levels
of staining for both CCN2 and CCN5.
Nervous system and ectodermally-derived tissues
CCN2 and CCN5 were found in ectodermally-derived
tissues of the mouse and rat, including the olfactory
epithelium and brain (Figs. 11, 12). In the mouse nasal
cavity, CCN2 and CCN5 were present in the cytoplasm and
some nuclei of all cell types of the olfactory epithelium and
lamina propria (Fig. 11).
CCN2 and CCN5 proteins were found in throughout the
cytoplasm of cells of the cerebrum of the rat brain, and in
many nuclei (Figs. 12, 13). The proportion of nuclei that
had nuclear localization of CCN2 and CCN5 varied widely
according to the region of the brain (data not shown).
Summary
CCN5 and CCN2 proteins were detected in all organs and
tissues examined in both mouse and rat. Immunohisto-
chemistry results for both mouse and rat tissues varied in
distribution and intensity among the different cell types in
each tissue tested (Tables 1, 2). Both proteins were most
commonly observed in the cytoplasm, varying in intensity
from low levels (e.g., spleen) to very high levels (e.g.,
stomach). The lowest levels of CCN2 and CCN5 among all
Fig. 9 Immunohistochemical analysis of the rat ovary using anti-CCN2
and anti-CCN5. The tissue sections (7 μm transverse) reveal the ovarian
cortex (COR), and demonstrate numerous small primordial follicles, and
several follicles of later maturational stages embedded within cortical
stroma cells. The largest follicles in the middle of each panel are Graafian
follicles, with an antrum (AN) and an oocyte (OOC) surrounded by
numerous cumulus follicle cells, and an outside layer of thecal cells (TH).
Many cells in the rat ovary, particularly the cumulus cells (CU),
demonstrate nuclear localization of CCN2 and CCN5. Both proteins are
also present in the oocyte, surrounded by the clear zona pellucida
R
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Fig. 10 Immunohistochemical analysis of the mouse thymus using
anti-CCN2 and anti-CCN5. The tissue sections (7 μm transverse)
reveal numerous lymphocytes in the cortex and medulla. The nuclei
are very large and almost completely fill each cell. Many lymphocytes
in the mouse thymus demonstrate nuclear localization of both CCN2
and CCN5. (Magnification=630×)
Fig. 11 Immunohistochemical analysis of the mouse olfactory epithelium
using anti-CCN2 and anti-CCN5. The tissue sections (7μm, coronal) show
all of the layers of the olfactory epithelium, with the ciliated columnar
epithelium of the nasal mucosa on the outside (CE), and the sustentacular
cell layer (SU), mature and immature bipolar olfactory neurons (ON),
globose and horizontal basal cells (BC), the cells of Bowman’s glands
(BG), and bone. Some cells from all regions of the mouse olfactory
system demonstrate nuclear localization of CCN2 and CCN5
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the tissues analyzed were observed in the spleen (data not
shown). In many tissues, such as heart, lung, stomach,
duodenum, kidney, ovary, thymus, olfactory epithelium,
brain, and 14-day gestation stage mouse brain, nuclear
staining was observed for both CCN2 and CCN5 (Tables 1, 2;
Fig. 13). In almost all tissues, the intensity and distribution
of CCN5 resembled that of CCN2 (Tables 1, 2).
Discussion
We expected that CCN5 protein would be present mostly in
smooth muscle, glandular epithelium, and endothelial cells,
and not in other tissues. Instead, CCN5 was found widely
distributed throughout all tissues of the adult mouse and rat.
Although we expected to find CCN2 mostly in endothelial
cells and connective tissue, and not in other tissues, it was
also found widely distributed throughout all rodent tissues
analyzed. Since the biological effects of CCN2 and CCN5
have been demonstrated to be opposite in many assays, we
expected that the distributions of both proteins would be
largely non-overlapping and complementary. Instead, both
proteins had very similar patterns of tissue distribution,
with only small differences in levels of expression. Because
we have not measured the affinity constants of either
antibody used, we cannot interpret the significance of
immunohistochemical staining differences. We expected
that CCN2 and CCN5 would localize only in the cytoplasm
or on cell surfaces. We were surprised to find that both
proteins were frequently present in the nuclei of many
tissues (Fig. 13).
We have previously demonstrated the presence of CCN5
protein in rat uterine smooth muscle and endometrial
glandular epithelium (Mason et al. 2004) and in rat arterial
smooth muscle (Lake et al. 2003). CCN5 has also been
described in human fetal bone (Kumar et al. 1999); human
pancreas (Dhar et al. 2007); and breast ductal and lobular
epithelium (Banerjee et al. 2003). CCN5 protein and
mRNA has also been detected in numerous cultured cells
and tissue specimens using Western and Northern blots,
respectively (summarized in Gray and Castellot 2004). The
results of some screening studies were extremely variable
and inconsistent, with an excess of negative findings in
some studies. For example, in one early survey of CCN5
mRNA expression using Northern blots, no CCN5 mRNA
was detected in most organs and tissues of the rat and mouse
(Zhang et al. 1998). It is possible that CCN5 and CCN2
proteins have a long half-life in adult tissues, and could have
been translated from very low levels of mRNA, or mRNA
present during an earlier stage of organogenesis. It is
unlikely that CCN5 is made in specific cells and then
transported via the blood to other tissues, since we have
been unable to detect it in blood plasma. It is also possible
Fig. 12 Immunohistochemical analysis of the rat brain using anti-
CCN2 and anti-CCN5. The tissue sections (7 μm parasagittal) were
made from the cerebral cortex of the rat brain. Many cells of the rat
cerebrum demonstrate nuclear localization of CCN2 and CCN5
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Fig. 13 Nuclear localization of CCN2 and CCN5 in mouse and rat cells. The indicated tissue sections (7 μm parasagittal) were incubated with
anti-CCN2 or anti-CCN5 and photographed at a magnification of 630×
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that some posttranslational modifications of CCN5 protein
might mask the epitopes detected by either antibody used in
this study, leading to undetected CCN5 proteins in some cell
types. Until the present studies, no comprehensive analysis
for CCN5 protein distribution in adult vertebrate tissues has
been reported.
As in the case of CCN5, no systematic studies of CCN2
protein expression in adult tissues have been reported.
Except for a few studies of normal tissue samples, most
CCN2 protein expression data are from studies of cultured
cells and tissues in pathological states. CCN2 protein has
been found in normal human bronchiolar epithelium (Chien
et al. 2006), chondrocytes of mouse and rat cartilage
(Fukunaga et al. 2003), and in all normal uterine cell types
in the mouse in patterns identical to our results in the rat
uterus with both CCN2 and CCN5 (Surveyor et al. 1998).
CCN2 mRNA has been localized using in situ hybridization
methods in muring ovarian granulosa cells in preantral
follicles (Harlow et al. 2002), in visceral epithelial cells of
the rat kidney (Ito et al. 2001), and in porcine uterine
smooth muscle, glandular epithelium, stromal, endothelial,
and luminal epithelial cells (Moussad and Brigstock 2000).
Fig. 13 (continued)
Table 1 Summary of mouse tissue CCN5 and CCN2 expression
Tissue CCN2 CCN5
Heart Cytoplasmic throughout ventricular and atrial myocardia
and valves
Cytoplasmic throughout ventricular and atrial myocardia
and valves
Lung Cytoplasmic in all cell types; many nuclei Cytoplasmic in all cell types; many nuclei
Stomach Cytoplasmic—all cell types; nuclear-gastric pit cells Cytoplasmic—all cell types; nuclear-gastric pit cells
Duodenum Cytoplasmic—all cell types; some nuclei in villi Cytoplasmic—all cell types; some nuclei in villi
Liver Cytoplasmic in all cell types Cytoplasmic in all cell types
Kidney Cytoplasmic in all cell types; many nuclei in all cell types Cytoplasmic in all cell types; many nuclei in all cell types
Ovary Cytoplasmic in all cell types; many nuclei among all cell
types
Cytoplasmic in all cell types; many nuclei among all cell
types
Pancreas Cytoplasmic in all cell types Cytoplasmic in all cell types
Thymus Cytoplasmic in all cells; nuclear in most cells Cytoplasmic in all cells; nuclear in most cells
Olfactory Cytoplasmic in most cell types; nuclear some cell types Cytoplasmic in most cell types; nuclear some cell types
Uterus Cytoplasmic in all cell types; nuclear in some stroma cells Cytoplasmic in all cell types; nuclear in some stroma cells
Fallopian tube Cytoplasmic in all cell types; nuclear in some stroma cells Cytoplasmic in all cell types; nuclear in some stroma cells
Skeletal
muscle
Cytoplasmic in all cells Cytoplasmic in all cells
Spleen Cytoplasmic in all cells Cytoplasmic in all cells
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The adult tissue CCN2 and CCN5 protein expression
distribution patterns are similar to those observed in tissues
of late gestation mouse embryos (Malmquist et al. 2007).
The present immunohistochemistry results have been
further corroborated by Western blot analyses of mouse
and rat tissue protein lysates (manuscript in preparation),
and in immunofluorescent microscopic analysis of cultured
cells prepared from many of the tissue types analyzed
(manuscript in preparation).
CCN2 and CCN3 proteins have been observed in the
nucleus in some cells (Wahab et al. 2001; Planque et al.
2006). Nuclear localization of CCN2 and CCN5 has also
been observed in cultured rat aortic, uterine, and tracheal
smooth muscle cells using immunofluorescent staining and
confocal microscopy methods (manuscript in preparation). In
both CCN2 and CCN3, the nuclear localization signal is
encoded by the CT domain. Experiments are underway to
determine which portion of CCN5 is necessary and sufficient
for nuclear localization in smooth muscle cells. Because
CCN5 does not have a CT domain, its nuclear localization
signal will be different from that of CCN2 and CCN3.
It has been suggested that CCN proteins in the nucleus
might interact with transcriptional regulatory proteins
(Planque 2006). Nuclear localization of CCN2 and CCN5
suggests the possibility of a direct mode of CCN protein
signaling that is separate from, or complementary to,
matricellular receptor-based mechanisms of regulating cell
signaling pathways and cell cycle control proteins.
Widespread expression of both CCN5 and CCN2
strongly suggests that both proteins have numerous func-
tions, most of which are not characterized. Since both
CCN2 and CCN5 are expressed in similar patterns, they
could be coordinately regulated by the same ligands and
intracellular signaling pathways in many cell types. Since
CCN5 and CCN2 frequently co-localize, they might
modulate the effects of each other at the physical level by
competing for or interfering with the same receptors. A
balance of pro-proliferative CCN proteins (such as CCN2)
and anti-proliferative CCN proteins (such as CCN5) might
be necessary in many cells and tissues to achieve homeo-
stasis, another potential example of a natural “yin-yang”
effect. Because its gene is non-redundant, CCN5 might be
necessary for all cell types, in contrast to the structural
redundancy of the other four-domain CCN proteins. Further
evidence for a vital role of CCN5 in vertebrates is the
observed lethal effect caused by changes in CCN5 dosage
during early embryonic development (data not shown).
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